QSAM You will have a hard time finding any other biotech/biopharma in Phase 1 with less than $100 million in market cap. Radiopharmaceutical companies are getting huge interest from investors. Bayer, the giant German drug company, just acquired two of them.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.